活动邀请 | 展望新时代下中美生物医药新格局

Core Insights - The article discusses the ongoing shifts in the global biopharmaceutical market due to multiple rounds of tariff changes initiated by the U.S., which are reshaping the industry landscape amid geopolitical uncertainties, accelerated merger trends, and the impact of AI technology [1]. Group 1: Event Overview - The ChinaBio International Cooperation Conference will feature a private dinner hosted by Bloomberg, focusing on the new dynamics of the U.S.-China biopharmaceutical landscape [1]. - The dinner will include a keynote speech on the new prospects for the biopharmaceutical industry in the "Trump 2.0" era and a thematic discussion on the development paths of Chinese pharmaceutical companies in light of geopolitical factors, merger trends, and AI technology [1]. Group 2: Key Speakers - Dr. Yang Dajun, co-founder, chairman, and CEO of Ascentage Pharma, will be a keynote speaker [1]. - Cao Ping, Senior Vice President and Chief Business Development Officer of Innovent Biologics, will also participate in the discussions [1].